Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-10 Sale |
2025-01-14 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
1,113 | $10.02 | $11,157 | 2,915,138 (Indirect) |
View |
| 2025-01-03 Sale(A) |
2025-01-10 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
833 | $11.85 | $9,871 | 2,918,467 (Indirect) |
View |
| 2025-01-06 Sale |
2025-01-08 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
2,216 | $10.08 | $22,336 | 2,916,251 (Indirect) |
View |
| 2024-01-03 Sale |
2025-01-06 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.89 | $47,543 | 2,918,467 (Indirect) |
View |
| 2024-12-30 Sale |
2025-01-02 4:06 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.4 | $49,600 | 2,922,467 (Indirect) |
View |
| 2024-12-26 Sale |
2024-12-30 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.64 | $50,553 | 2,926,467 (Indirect) |
View |
| 2024-12-23 Sale |
2024-12-26 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.1 | $48,399 | 2,930,467 (Indirect) |
View |
| 2024-12-19 Sale |
2024-12-23 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.86 | $43,440 | 2,934,467 (Indirect) |
View |
| 2024-12-17 Sale |
2024-12-19 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.21 | $44,852 | 2,938,467 (Indirect) |
View |
| 2024-06-28 Sale |
2024-07-01 6:00 pm |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
3,452 | $12 | $41,438 | 280,476 (Indirect Direct) |
View |
| 2024-05-01 Sale |
2024-05-02 6:19 pm |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
20,000 | $14.13 | $282,577 | 283,928 (Indirect Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
20,000 | $16.15 | $323,000 | 303,928 (Indirect Direct) |
View |
| 2024-03-15 Sale |
2024-03-19 4:47 pm |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
20,000 | $17.26 | $345,200 | 323,928 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-05 Option Award |
2025-01-07 4:05 pm |
N/A 2035-01-05 |
GYRE THERAPEUTICS INC. | GYRE | Zhang Ping Director |
52,000 | $0 | 52,000 (Direct) |
View |
| 2024-08-14 Option Award |
2024-08-16 9:13 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Nussbaum Rodney L Director |
52,000 | $0 | 52,000 (Direct) |
View |
| 2024-08-14 Option Award |
2024-08-16 9:10 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Parry Renate Director |
52,000 | $0 | 52,000 (Direct) |
View |
| 2024-08-14 Option Award |
2024-08-16 9:07 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Epstein David M. Director |
52,000 | $0 | 52,000 (Direct) |
View |
| 2024-08-14 Option Award |
2024-08-16 9:05 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Carmichael Gordon Director |
52,000 | $0 | 52,000 (Direct) |
View |
| 2024-08-14 Option Award |
2024-08-16 9:01 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-08-14 Option Award |
2024-08-16 8:58 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-08-14 Option Award |
2024-08-16 8:56 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-08-14 Option Award |
2024-08-16 8:53 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Chen Ruoyu Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-08-14 Option Award |
2024-08-16 8:50 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Ying Han Chief Executive Officer |
341,000 | $0 | 341,000 (Direct) |
View |
| 2024-08-06 Option Award |
2024-08-08 4:31 pm |
N/A 2034-08-06 |
GYRE THERAPEUTICS INC. | GYRE | Epstein David M. Director |
1,866 | $0 | 1,866 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-01 6:00 pm |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
3,452 | $0 | 280,476 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-01 6:00 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
3,452 | $6.93 | 280,476 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-02 6:19 pm |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
20,000 | $0 | 283,928 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-02 6:19 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
20,000 | $6.93 | 283,928 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 4:01 pm |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
20,000 | $0 | 303,928 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 4:01 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
20,000 | $6.93 | 303,928 (Direct) |
View |
| 2024-03-20 Option Award |
2024-03-21 8:31 pm |
N/A 2034-03-20 |
GYRE THERAPEUTICS INC. | GYRE | Nussbaum Rodney L Director |
1,866 | $0 | 1,866 (Direct) |
View |
| 2024-03-15 Exercise |
2024-03-19 4:47 pm |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
20,000 | $0 | 323,928 (Direct) |
View |
| 2024-03-15 Exercise |
2024-03-19 4:47 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
20,000 | $6.93 | 323,928 (Direct) |
View |
| 2023-10-30 Other |
2023-11-22 7:55 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director |
2,840,376 | $0 | 11,294,404 (Indirect) |
View |
| 2023-11-20 Option Award |
2023-11-22 7:55 pm |
N/A 2030-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director |
5,613,652 | $0 | 11,294,404 (Direct) |
View |
| 2023-11-20 Option Award |
2023-11-22 7:49 pm |
N/A 2030-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer |
1,665,115 | $0 | 1,665,115 (Direct) |
View |
| 2023-11-20 Option Award |
2023-11-22 7:40 pm |
N/A 2030-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,510,047 | $0 | 4,510,047 (Direct) |
View |
| 2023-11-20 Option Award |
2023-11-22 7:34 pm |
N/A 2030-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Chen Ruoyu Chief Financial Officer |
578,540 | $0 | 578,540 (Direct) |
View |
| 2023-10-30 Other |
2023-11-22 7:27 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | GNI Group Ltd. GNI USA Inc. 10% Owner |
63,588,119 | $0 | 127,594,006 (Indirect) |
View |
| 2023-11-20 Option Award |
2023-11-22 7:20 pm |
N/A 2030-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Wu Charles C Chief Executive Officer |
170,417 | $0 | 170,417 (Direct) |
View |
Ownership(A) |
2023-11-22 7:06 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
0 | $0 | 2,942,467 (Indirect) |
View |
| 2023-10-31 Option Award |
2023-11-01 06:15 am |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director |
1,866 | $0 | 1,866 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-01 06:15 am |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director |
316,518 | $0 | 316,518 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-01 06:15 am |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Parry Renate Director |
1,866 | $0 | 1,866 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-01 06:15 am |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Chen Ruoyu Interim CFO |
34,380 | $0 | 34,380 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-01 06:15 am |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director |
343,518 | $0 | 343,518 (Direct) |
View |